NICOLE VOTAW: Open Payments
NPI 1821425133 · TYE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$670 in 28 payments from 5 companies in 2025. Trend: 2023 $387 · 2024 $525 · 2025 $670
Food & beverage: $670
| Company | Payments | Amount |
|---|---|---|
| Verona Pharma, Inc. | 14 | $228 |
| AstraZeneca Pharmaceuticals LP | 5 | $228 |
| Novo Nordisk Inc | 7 | $179 |
| Lilly USA, LLC | 1 | $19 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $16 |
Products named: Ohtuvayre, AIRSUPRA, Ozempic, FARXIGA, Wegovy, MOUNJARO, XIFAXAN.
Industry payments across TX — which companies pay providers there.
